Status:
RECRUITING
Preoperative Stereotactic Radiotherapy for Treatment of Spinal Metastases
Lead Sponsor:
University Medical Center Goettingen
Conditions:
Spinal Metastases
Solid Tumor Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this interventional clinical trial is to evaluate the efficacy and safety of preoperative hypofractionated Stereotactic Body Radiotherapy (SBRT) in the treatment of patients undergoing sur...
Eligibility Criteria
Inclusion
- Indication for surgical treatment of a spinal tumor
- Age: older or 18 years
- Estimated survival \> 6 months
- The patient is able to understand the nature, significance and scope of the clinical study in the context of patient information and to base the decision to participate in the study on this.
Exclusion
- Age: \< 18 years
- Motor deficit or loss of bladder and bowel control that urges an emergency surgical decompression
- Tumor extent does not allow hypofractioned SBRT (1-3 fractions)
Key Trial Info
Start Date :
August 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07135817
Start Date
August 1 2025
End Date
January 1 2027
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Goettingen
Göttingen, Germany, 37073